56 reports

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

The MicroPEARLS spray freezing technology allows for the timely release of these two key nutrients throughout an animal' s gastrointestinal (GI) tract.

  • Antiviral
  • Mineral Supplement
  • Market Size
  • Ajinomoto Co., Inc.
  • Cargill Inc.
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand

It is used to enhance rumen and gastrointestinal tract function.

  • Cattle
  • Mineral Supplement
  • World
  • Market Size
  • Nutreco N.V.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Antiviral
  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • ATRIPLA SWOT ANALYSIS, 2016

BIOSCIENCE TRENDS; ##(##): ##-##.

  • Antiviral
  • Mineral Supplement
  • East Asia
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.

Genotype ## is the most common HCV.

  • Antiviral
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

The alleviation of gastrointestinal morbidity and other diseases in livestock, such as swine dysentery and acidosis in ruminants, is another advantage of feed ingredients enzymes.

  • Mineral Supplement
  • Colombia
  • South America
  • Market Size
  • Alltech Inc.

MARKET SEGMENTATION ##.

  • Mineral Supplement
  • Argentina
  • Croda International Plc
  • Danone SA
  • General Mills, Inc.

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

Develops drugs for the treatment of inflammatory and gastrointestinal diseases.

  • Antiviral
  • China
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Vendor landscape

China has about one fertility center for every ##. ## million individuals, while the US has one center for every ##, ## individuals.

  • Antiviral
  • United States
  • Demographic
  • Ferring International Center S.A.
  • Merck & Co., Inc.

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Antiviral
  • Mineral Supplement
  • North America
  • United States
  • Demand

You can easily book an appointment with one online.

  • Antiviral
  • United States
  • CooperSurgical, Inc.
  • Ferring International Center S.A.
  • Merck & Co., Inc.
  • Other prominent vendors

A single cause in one of the partners or a combination of factors, either in one or both partners, can lead to infertility.

  • Antiviral
  • United States
  • CooperSurgical, Inc.
  • Merck & Co., Inc.
  • Monash IVF Group Limited

Elvitegravir inhibits HIV-## integrase.

  • Antiviral
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc

HIV

4546 5000 3864
  • Reyataz late-phase trial data in HIV-1 infection
  • Reyataz pivotal trial data in HIV-1 infection

Gastrointestinal (GI) toxicities were documented in a similar percentage of patients in the Tybost (##. ##%) and Norvir (##. ##%) treatment arms.

  • Antiviral
  • Europe
  • European Union
  • North America
  • United States

References P##(SHC) Therapeutic Area/ Disease Indications Diabetes Gastrointestinal lesions University of Bari Aldo Moro, Italy.

  • Antiviral
  • Insulin
  • United States
  • MC2 Biotek Group
  • POXEL SA

THE MOLECULES THAT BLOCK PD-## PATHWAY INHIBIT THE INTERACTION BETWEEN PD- ## AND ITS LIGANDS (PDL-## AND PDL-##).

  • Antiviral
  • North America
  • United States
  • Incyte Corporation
  • Merck & Co., Inc.
  • Clinical Trial profile. 187 Trial Title
  • Clinical Trial profile. 341 Trial Title

The prominent features of this report are - ##.

  • Antiviral
  • Cytokine
  • Mineral Supplement
  • Pharmaceutical
  • World
  • ACYCLOVIR SWOT ANALYSIS, 2014

VALACYCLOVIR IS AVAILABLE FOR ORAL ADMINISTRATION AND HAS THREE- TO FIVE- FOLD HIGHER BIOAVAILABILITY THAN ORAL ACYCLOVIR DUE TO ITS BETTER ABSORPTION BY THE HUMAN GASTROINTESTINAL TRACT (SOUL-LAWTON ET AL., 1995).

  • Antiviral
  • Mineral Supplement
  • United States
  • Forecast
  • Genocea Biosciences, Inc.
  • TERIPARATIDE - DRUG PROFILE
  • also announced that it is expected to be available in the second quarter of 2015.

It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases.

  • Antiviral
  • Endocrine Disease
  • Mineral Supplement
  • United States
  • World
  • Hetero Drugs Ltd, Deals By Therapy Area, 2012 to YTD 2018
  • Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir

The drug candidate acts by inhibiting Gag protein (HIV-## Maturation Inhibitor).

  • Antiviral
  • Healthcare
  • HIV AIDS
  • Mineral Supplement
  • Pharmaceutical

Christian Bréchot, one of the world' s most distinguished infectious diseases experts.

  • Antiviral
  • Pharmaceutical
  • France
  • Company
  • ABIVAX
  • Medivir AB, Deals By Therapy Area, 2012 to YTD 2018

This agreement enables Beactica to advance one of their prioritized discovery programmes and enables Medivir to search for hits active against one of its early discovery targets.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • Sweden
  • Medivir UK Ltd.
  • BRINCIDOFOVIR - DRUG PROFILE

Gastrointestinal (GI) side effects were absent.

  • Antiviral
  • Therapy
  • United States
  • Product Initiative
  • Chimerix, Inc.

The estimated cost of the Phase II trial is under $## million.

  • Antiviral
  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Can-Fite BioPharma Ltd.